Corbus Pharmaceuticals Holdings Inc. Company Name:
CRBP Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Corbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update PR Newswire Promising pre-clinical data generated for CRB-601 across several tumor models as monotherapy and in combination with anti-PD1 therapy IND submission...
Corbus Presents Latest Preclinical Data for CRB-601 at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference PR Newswire CRB-601 is a highly potent and selective anti -αvβ8 integrin monoclonal antibody designed to block t...
Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update PR Newswire Promising pre-clinical data generated for CRB-601 across several tumor models as monotherapy and in combination with anti-PD1 therapy IND submission ...